ADMA BIOLOGICS, INC. Quarterly Common Stock, Shares, Issued from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Adma Biologics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2011 to Q3 2024.
  • Adma Biologics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 236M shares, a 4.61% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 236M +10.4M +4.61% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 233M +8.5M +3.79% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 232M +9.51M +4.28% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 226M +4.25M +1.91% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 226M +29.2M +14.8% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 225M +28.2M +14.3% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 222M +25.9M +13.2% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 222M +26M +13.3% Dec 31, 2022 10-K 2024-02-28
Q3 2022 197M +58.5M +42.3% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 196M +64.5M +48.9% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 196M +73.3M +59.6% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 196M +90.9M +86.7% Dec 31, 2021 10-K 2023-03-23
Q3 2021 138M +48.7M +54.3% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 132M +45.5M +52.7% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 123M +36.7M +42.5% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 105M +45.6M +76.8% Dec 31, 2020 10-K 2022-03-24
Q3 2020 89.6M +30.3M +51.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 86.3M +27M +45.6% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 86.3M +40M +86.3% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 59.3M +13M +28% Dec 31, 2019 10-K 2021-03-25
Q3 2019 59.3M +13M +28% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 59.3M +13M +28% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 46.4M +9.63M +26.2% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 46.4M +9.63M +26.2% Dec 31, 2018 10-K 2020-03-13
Q3 2018 46.4M +29.1M +169% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 46.3M +29.2M +170% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 36.7M +23.8M +185% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 36.7M +23.8M +185% Dec 31, 2017 10-K 2019-03-13
Q3 2017 17.2M +4.32M +33.5% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 17.2M +4.3M +33.3% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 12.9M +2.17M +20.3% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 12.9M +2.17M +20.3% Dec 31, 2016 10-K 2018-03-29
Q3 2016 12.9M +2.17M +20.3% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 12.9M +2.18M +20.4% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 10.7M +7.51K +0.07% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 10.7M +1.42M +15.3% Dec 31, 2015 10-K 2017-02-24
Q3 2015 10.7M +1.42M +15.3% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 10.7M +1.41M +15.2% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 10.7M +1.41M +15.2% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 9.29M 0 0% Dec 31, 2014 10-K 2016-03-23
Q3 2014 9.29M +3.42M +58.3% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 9.29M +3.42M +58.3% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 9.29M +3.42M +58.3% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 9.29M +3.42M +58.3% Dec 31, 2013 10-K 2015-03-09
Q3 2013 5.87M +1.22M +26.1% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 5.87M +1.22M +26.1% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 5.87M +1.22M +26.1% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 5.87M +5.46M +1337% Dec 31, 2012 10-K 2014-03-28
Q3 2012 4.65M +2.15M +86.2% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 4.65M +2.15M +86.2% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 4.65M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 409K Dec 31, 2011 10-K 2013-03-06
Q3 2011 2.5M Sep 30, 2011 10-Q 2011-10-28
Q2 2011 2.5M Jun 30, 2011 10-Q 2012-02-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.